Lately, some evidences have suggested that various transcription factors, such as JAK2/STAT3 [48, 49], NF-kB [50], PI3K/AKT/mTOR [51] and MEK1/2/ERK1/2 [52] facilitate the transcription of PD-L1 in cancer. Here, MTOR is linked to cancer.